###begin article-title 0
Novel RNA-binding properties of the MTG chromatin regulatory proteins
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 477 488 477 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
The myeloid translocation gene (MTG) proteins are non-DNA-binding transcriptional regulators capable of interacting with chromatin modifying proteins. As a consequence of leukemia-associated chromosomal translocations, two of the MTG proteins, MTG8 and MTG16, are fused to the DNA-binding domain of AML1, a transcriptional activator crucial for hematopoiesis. The AML1-MTG fusion proteins, as the wild type MTGs, display four conserved homology regions (NHR1-4) related to the Drosophila nervy protein. Structural protein analyses led us to test the hypothesis that specific MTG domains may mediate RNA binding.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
By using an RNA-binding assay based on synthetic RNA homopolymers and a panel of MTG deletion mutants, here we show that all the MTG proteins can bind RNA. The RNA-binding properties can be traced to two regions: the Zinc finger domains in the NHR4, which mediate Zinc-dependent RNA binding, and a novel short basic region (SBR) upstream of the NHR2, which mediates Zinc-independent RNA binding. The two AML1-MTG fusion proteins, retaining both the Zinc fingers domains and the SBR, also display RNA-binding properties.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 140 149 140 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
Evidence has been accumulating that RNA plays a role in transcriptional control. Both wild type MTGs and chimeric AML1-MTG proteins display in vitro RNA-binding properties, thus opening new perspectives on the possible involvement of an RNA component in MTG-mediated chromatin regulation.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 104 105 104 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 127 128 127 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 151 152 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 227 238 227 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 307 308 307 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 541 542 541 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 662 663 662 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 664 665 664 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 768 770 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 878 880 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 881 883 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 884 886 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1028 1030 1028 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1031 1033 1031 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1034 1036 1034 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1037 1039 1037 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1088 1090 1088 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1091 1093 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1094 1096 1094 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1215 1217 1215 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1218 1220 1218 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1221 1223 1221 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1224 1226 1224 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1416 1418 1416 1418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 67 72 <span type="species:ncbi:9606">human</span>
The myeloid translocation gene (MTG) protein family includes three human members: MTG8 (ETO/CBFA2T1) [1-3], MTGR1 (CBFA2T2) [4-6] and MTG16 (CBFA2T3) [7]. The MTG proteins share four conserved domains that can be traced to the Drosophila protein nervy, and therefore called nervy homology regions (NHR1-4) [6]. These domains carry information for distinct, but integrated, functional properties. The NHR1 domain can positively or negatively modulate transcription through interaction with either co-repressors or transcriptional activators [8]. The NHR2 domain is required for interaction with other MTG proteins and with the transcriptional co-repressor Sin3A [6,9-11]. The NHR4 domain, even if it contains two zinc finger (ZF) domains, does not mediate DNA-binding [12,13]; instead, it binds both co-repressor proteins, including N-CoR/SMRT, and histone deacetylases (HDACs) [11,14,15]. We and others showed that the MTG proteins can act as chromatin repressors due to their ability to recruit HDAC activity, either directly [10,11,16,17] or via the co-repressors N-CoR/SMRT and Sin3A [14,15,18]. Further, it has been demonstrated that both MTG8 and MTG16 can induce transcriptional repression of reporter genes [10,15,17,19]. Since the MTG proteins do not bind to DNA directly, their transcriptional repressive action is dependent on the binding to transcription factors able to recognize specific target-genes ([20] and references within).
###end p 9
###begin p 10
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 540 542 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 551 560 551 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 679 681 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
As a consequence of the leukemia-associated chromosomal translocations t(8;21) and t(16;21), MTG8 and MTG16 are fused to AML1 (RUNX1), a transcription factor crucial for hematopoiesis. The resulting fusion proteins AML1-MTG8 (AML1-ETO) and AML1-MTG16 retain the DNA-binding domain of AML1 (Runt Homology Domain, RHD) and all the four functional NHR domains of the MTG proteins (for detailed reviews see [12,21-24]). Both AML1-MTG8 and AML1-MTG16 can bind to AML1-target genes, recruit HDAC activity, and induce a repressed chromatin state [20,25-27]. In vitro studies suggest that epigenetic downregulation/silencing of these target genes may be a key step in leukemogenesis [12,21-24].
###end p 10
###begin p 11
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 687 689 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
More and more evidence has been accumulating that RNA, in particular non-coding RNA (ncRNA), can play an important role in the epigenetic control of chromatin [28-30]. The MTG proteins are transcriptional regulators equipped with non-DNA-binding ZF domains, which have been described to mediate protein-RNA interactions in other proteins [31]. Based on this observation, we previously hypothesized that transcriptional regulation by the MTG proteins might involve an RNA component [20]. To start to address this hypothesis, we set out to investigate whether the MTG proteins have RNA-binding properties. By using a well established RNA-binding assay based on synthetic RNA homopolymers [32], here we show that indeed this is the case. Two regions mediate the RNA binding: the zinc-finger domains in the NHR4 region and a novel RNA-binding short basic region (SBR) proximal to the NHR2 region. We further show that the two oncogenic fusion proteins AML1-MTG8 and AML1-MTG16, retaining these two regions, maintain also RNA-binding properties.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
The MTG proteins have RNA-binding properties
###end title 13
###begin p 14
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1040 1042 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1207 1209 1207 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
We investigated the RNA-binding properties of MTG8, MTG16 and MTGR1 by analyzing their ability to interact with four synthetic RNA homopolymers, poly(A), poly(C), poly(G) and poly(U), coupled to Sepharose beads. This method has been previously proven to be suitable for studying RNA-binding properties of RNA-binding proteins, including the Fragile x mental retardation protein FMRP, which we used in this study as a positive control [33-35]. The three MTGs, exogenously expressed in COS cells, display binding to both poly(U) and poly(G), but no binding to poly(A) and poly(C), thus showing the same properties of the control RNA-binding protein FMRP (Figure 1A). All MTGs did not bind uncoupled Sepharose beads, indicating specific affinity for RNA (Figure 1A). For the remainder of this study we chose to use only poly(U) RNA. Digestion with micrococcal nuclease of the Sepharose-conjugated poly(U) homopolymer apparently abolishes MTGs precipitation (here shown for MTG16), demonstrating that the binding occurs via poly(U) RNA (Figure 1B). In addition, we showed that known non-RNA-binding proteins, such as BSA and GFP, were not able to bind poly(U) RNA under the experimental conditions used (Figure 1B). These indicate that the RNA-binding properties of the MTG proteins are specific.
###end p 14
###begin p 15
###xml 0 44 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The MTG proteins have RNA-binding properties</bold>
###xml 46 47 46 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 387 388 387 388 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 656 657 655 656 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 811 814 810 813 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D) </bold>
###xml 814 823 813 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
The MTG proteins have RNA-binding properties. A. RNA-binding assay using Sepharose-conjugated RNA homopolymers followed by Western Blotting shows that MTG8, MTG16 and MTGR1 exogenously expressed in COS cells bind to poly(G) and poly(U), while do not bind to poly(A), poly(C) and uncoupled Sepharose beads. FMRP, which we used as a positive control, shows similar RNA-binding properties. B. Binding specificity is shown both by the MTG inability to bind poly(U) after digestion with micrococcal nuclease (shown here for MTG16), and by the inability to bind poly(U) of two non-RNA-binding proteins, BSA (10 mug) and GFP (transiently expressed in COS cells). C. Poly(U)-binding at different concentrations of NaCl shows the strength of RNA interaction of the MTG proteins and the control RNA-binding protein FMRP. D) In vitro transcribed and translated (TnT) MTG proteins maintain the ability to bind poly(U).
###end p 15
###begin p 16
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
Next, we determined the strength of MTGs binding to poly(U) beads in the presence of 150, 250, 500 and 1000 mM NaCl. All MTGs bound the poly(U) homopolymer at the physiological salt concentration of 150 mM (Figure 1C). The binding was stable up to 250 mM NaCl, while it weakened at higher salt concentrations (Figure 1C), which is not uncommon for other RNA-binding proteins [36,37]. The RNA-binding strength of the MTG proteins is similar to the one reported for RNA-binding proteins that, like the MTGs [20], have multiple functions [38].
###end p 16
###begin p 17
###xml 142 151 142 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
Finally, we investigated the influence of posttranslational modifications of the MTG proteins on the RNA binding. MTG proteins produced in an in vitro transcription/translation system, in which posttranslational modifications do not occur, retained the ability to interact with poly(U) RNA (Figure 1D). This indicates that posttranslational modifications are not directly necessary for the observed RNA binding.
###end p 17
###begin title 18
Deletion of the Zinc-finger domains is not sufficient to abolish RNA-binding properties
###end title 18
###begin p 19
###xml 89 90 89 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 218 228 218 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In silico </italic>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 649 651 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 727 729 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1019 1021 1019 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1169 1171 1169 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1241 1243 1241 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1395 1403 1395 1403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1541 1543 1533 1535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1602 1604 1594 1596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1614 1616 1606 1608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1835 1837 1823 1825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 2054 2056 2038 2040 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 2064 2066 2048 2050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 2239 2241 2219 2221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
The NHR4, a region conserved across all the MTGs, contains two Zinc Finger (ZF) domains [6]. ZF domains are known to have DNA-binding properties, but they have been described to mediate also interaction with RNA [31]. In silico analysis of the MTG8 NHR4 structure indeed suggests that this region is a putative RNA-binding domain. First, we analyzed the primary structure of the NHR4 region by using the BindN program [39]. This analysis predicted several RNA-binding residues between aminoacid 516 and 542 (Figure 2A, left). Further, we analyzed the MTG8 NHR4 solution structure, previously solved by nuclear magnetic resonance (NMR) spectroscopy [40] and deposited in the Protein Data Bank (PDB), by using Patch Finder Plus [41,42]. The Patch Finder Plus algorithm extracts from the three-dimensional (3D) protein structure positively charged electrostatic patches, which are known to mediate protein-nucleic-acid interactions. The algorithm predicted on the surface of the NHR4 domain a large positive patch (Figure 2A, right), whose amino acid residues partially overlap with the RNA-binding residues predicted by the analysis of the NHR4 primary structure (Figure 2A, left). Because the MTG proteins do not have DNA-binding properties [13], it is conceivable to hypothesize that this positive patch mediates protein-RNA binding. For this reason, we further tested the predicted RNA-binding in vitro, by developing two MTG8 deletion mutants either lacking the ZF-containing C-terminus (MTG8Delta1) or the N-terminus (MTG8Delta2) (Figure 2B, left). The MTG8 epitope recognized by our AB-8 antibody [16] (Figure 2B, left) allowed the detection of these deletion mutants without using protein tags, which might interfere with the RNA-binding. Deletion of the MTG8 C-terminus (MTG8Delta1) did not affect the binding to poly(U) (Figure 2B, right), thus indicating that RNA-binding domains other than the ZF might be present. This supposition is further supported by the observation that both MTG8 and MTG8Delta1 bind to poly(U) even in the absence of ZnCl2 (Figure 2B, right), which would be necessary for a ZF-mediated interaction. Since deletion of MTG8 N-terminus (MTG8Delta2) did not abolish Zinc-independent binding to poly(U) (Figure 2B, right), we hypothesized the presence of an additional RNA-binding domain common to the two deletion mutants, in the region encompassing a.a. 305-447.
###end p 19
###begin p 20
###xml 0 95 0 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Deletion of the Zinc finger domains in the NHR4 region is not sufficient to abolish RNA binding</bold>
###xml 97 98 97 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 100 110 100 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In silico </italic>
###xml 310 311 310 311 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 555 557 555 557 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
Deletion of the Zinc finger domains in the NHR4 region is not sufficient to abolish RNA binding. A. In silico analysis of the MTG8 NHR4 domain primary structure (left) and solution structure (right), performed by using BindN and Path Finder Plus, respectively, identifies putative RNA-binding residues (left). B. Scheme of the MTG8 deletion mutants showing MTGs conserved domains (NHRs), the zinc finger (ZF) domains and the epitope recognized by the anti-MTG8 antibody (AB-8) (left). Poly(U)-binding assay performed in the presence or the absence of ZnCl2 (50 muM) shows that neither deletion of MTG8 C-terminus (MTG8Delta1), containing the ZF domains, nor deletion of the N-terminus (MTG8Delta2) are sufficient to abrogate the binding (right).
###end p 20
###begin title 21
Identification of a Zinc-independent RNA-binding domain proximal to the NHR2 region
###end title 21
###begin p 22
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 736 738 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 896 898 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 1108 1116 1108 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1276 1278 1268 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 1351 1353 1339 1341 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1361 1363 1349 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 1642 1644 1626 1628 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1652 1654 1636 1638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 501 506 <span type="species:ncbi:9606">human</span>
###xml 871 878 <span type="species:ncbi:8355">Xenopus</span>
###xml 882 887 <span type="species:ncbi:9606">Human</span>
To search for potential RNA-binding domains other than the NHR4 in the MTG8 protein, we used, in addition to BindN, a second software, RNAbindR. RNAbindR is a computational tool able to predict RNA-binding amino acids from a protein primary sequence, based on interactions from structures of known protein-RNA complexes [43]. Both programs predicted an MTG8 region rich in RNA-binding residues between a.a. 310 and a.a. 333 (Figure 3A, top). Analysis of the MTG8 sequence from other species and other human MTG proteins identified a conserved short basic region (which we named SBR) within a.a. 309 and a.a. 328 (Figure 3A, bottom). This region has a high content in basic amino acids, which are often involved in nucleic acid binding [44]. Specifically, the arginines at position 312, 321, 324 and 326 and other basic residues at position 317 and 358 are conserved from Xenopus to Human (Figure 3A, bottom). Since the three-dimensional structure of the SBR is not known, we could not test for the presence of positively charged protein patches. However, we established the RNA-binding properties of the SBR in vitro. By deleting the SBR from MTG8Delta1, we obtained the deletion mutant MTG8Delta3, which lacks a.a. 1-329, but retains the ZF domains in the C-terminus (Figure 3B, left). MTG8Delta3 was able to bind poly(U) only in the presence of ZnCl2 (Figure 3B, right), indicating that the SBR is responsible for the Zinc-independent binding to RNA. Another deletion mutant, MTG8Delta4, missing both the zinc-finger domain and the N-terminal part, including the SBR, did not bind to poly(U) either in the presence or in the absence of ZnCl2 (Figure 3B, right), indicating that the ZF domains mediate the Zinc-dependent RNA-binding. In conclusion, two regions mediate MTG8 RNA-binding: the canonical ZF domains in the NHR4 region and a novel Zinc-independent RNA-binding domain corresponding to the SBR region.
###end p 22
###begin p 23
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Identification of SBR, a novel RNA-binding domains proximal to NHR2</bold>
###xml 69 70 69 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 72 82 72 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In silico </italic>
###xml 368 369 368 369 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 318 323 <span type="species:ncbi:9606">human</span>
Identification of SBR, a novel RNA-binding domains proximal to NHR2. A. In silico analysis of the MTG8 protein sequence with BindN and RNAbindR software predicts RNA-binding residues in a region between a.a. 316 and a.a. 333 (top). This sequence is part of a short basic region (SBR) highly conserved across the three human MTGs and across different species (bottom). B. Deletion of MTG8 N-terminus, containing the SBR (MTG8Delta3), abrogates Zinc-independent poly(U)-binding; further deletion of MTG8 C-terminus, containing the Zinc Finger (ZF) domains (MTG8Delta4), abrogates also Zinc-dependent poly(U)-binding.
###end p 23
###begin title 24
The fusion proteins AML1-MTG8 and AML1-MTG16 retain the RNA-binding properties of wild type MTGs
###end title 24
###begin p 25
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 254 255 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 515 517 515 517 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 525 527 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
As a consequence of the leukemia-associated chromosome translocations t(8;21) and t(16;21), almost the entire MTG8 and MTG16 protein moieties are fused to the RHD domain of AML1, leading to the chimeric AML1-MTG8 and AML1-MTG16 proteins, respectively [1-3]. These chimeric proteins retain the AML1 DNA-binding domain and all the MTGs functional domains, including the ZF and the SBR RNA-binding domains (Figure 4A). Here we show that both fusion proteins bind to poly(U) both in the presence and the absence of ZnCl2 (Figure 4B), thus indicating that the RNA-binding properties of the wild type MTG proteins are maintained in their chimeric counterparts.
###end p 25
###begin p 26
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">AML1-MTGs fusion proteins maintain MTGs RNA-binding properties</bold>
###xml 64 65 64 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 147 148 147 148 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 244 245 244 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
AML1-MTGs fusion proteins maintain MTGs RNA-binding properties. A. Both the ZF domains and the SBR region are present in AML1-MTG8 and AML1-MTG16. B. AML1-MTG8 and AML1-MTG16 are able to bind poly(U) both in the presence and the absence of ZnCl2.
###end p 26
###begin title 27
Discussion
###end title 27
###begin p 28
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 607 618 607 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 810 812 810 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 813 815 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
The MTG proteins are transcriptional regulators capable of networking with their own family protein members and a variety of transcriptional regulatory proteins. Apparently, the major MTGs' action relies on the ability of these adaptor proteins to establish multiple interactions, on one hand with canonical DNA-binding transcription factors and, on the other hand, with chromatin regulatory proteins, including repressor proteins and histone modifying enzymes (reviewed in [20]). The MTGs carry out distinct, but integrated, functional interactions through conserved domains, the NHR1-4, homologous to the Drosophila protein Nervy. Despite the presence of two zinc finger (ZF) motifs in one of the domains (NHR4), the MTG proteins do not exert their transcriptional regulatory function by direct DNA binding [12,13].
###end p 28
###begin p 29
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 302 311 302 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 824 834 824 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 1284 1286 1284 1286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1324 1334 1324 1334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bona fide </italic>
###xml 1446 1448 1446 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1139 1144 <span type="species:ncbi:9606">human</span>
Based on the observation that ZF motifs can mediate not only DNA-protein interactions, but also RNA-protein interactions [44], we previously hypothesized that the ZF-containing NHR4 domain could confer RNA-binding properties to both wild type and chimeric MTG proteins [20]. In this study, by using an in vitro assay based on RNA homopolymers binding [32], we show that the MTG proteins specifically bind to RNA. We unequivocally demonstrate the binding specificity by performing a series of experiments. First, we showed that non-RNA-binding proteins cannot be precipitated by RNA hompolymers under the same conditions used for the MTGs. Second, digestion of the poly(U) RNA homopolymer completely abolished the MTGs binding. Finally, the MTG-RNA interaction was abrogated by deletion of specific MTG domains. By combining in silico protein analyses and development of MTG deletion mutants, we found that the RNA binding is not only mediated by the ZF domains in the NHR4 region, but entails also a novel, Zinc-independent, RNA-binding region proximal to NHR2, the SBR region. The SBR domain seems to be highly conserved across the three human MTGs and the MTGs of different species, and it is rich in basic amino acid residues, a feature frequently observed in RNA binding domains [44]. To our knowledge, this region is a bona fide novel RNA binding domain, whose primary and secondary structures do not resemble canonical RNA-binding domains [44].
###end p 29
###begin p 30
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 355 364 355 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
The aberrant AML1-MTG fusion proteins retain the ability of interplaying with both repressor proteins and/or histone modifying enzymes, and can induce an altered epigenetic status at the chromatin of both coding and non-coding AML1-target genes [26,27,45]. Apparently, the fusion of two MTGs, MTG8 and MTG16, to the RHD region of AML1 does not affect the in vitro RNA-binding properties.
###end p 30
###begin p 31
###xml 57 65 57 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
Whether the wild type and chimeric MTG proteins bind RNA in vivo remains to be established. The MTG proteins, like the well-known RNA-binding protein FMRP [33], bind preferentially to poly(U) and poly(G). This might suggest a potential affinity for RNAs rich in U and/or G, such as mRNAs containing short tandem repeats (STR) made of GU dinucleotides [46] or long poly(U) stretches ([32] and references within) in their 3'untranslated region (UTR). Further, based on the strength of RNA binding, the MTG proteins might mediate transient protein-RNA interactions. It is noteworthy that transient RNA-protein interactions often characterize multifunctional proteins, such as chaperone proteins, with RNA-binding strengths similar to the ones displayed by the MTGs [38].
###end p 31
###begin p 32
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 833 835 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
Interestingly, the two domains that we found to be involved in RNA binding in either a Zinc-dependent or a Zinc-independent fashion are also capable of interacting with specific chromatin regulatory proteins. Specifically, the ZF-containing NHR4 domain is known to interact with both the N-CoR/SMRT proteins and HDACs [10,11,14,15,18], while the SBR domain is overlapping with a region (aa. 300-343) involved in HDAC3 binding [11]. Whether an RNA component initiates, or contributes, to the assembly of MTGs-containing repressor complexes at specific target sites in the genome remains to be established. A growing number of RNAs, including non-coding RNAs, appears to be implicated in chromatin architecture and chromatin-mediated transcriptional regulation [28-30]. Due to the already known networking ability of the MTG proteins [20], it is possible that these family of proteins are even more versatile than originally expected, being capable of networking regulatory RNA in addition to chromatin regulatory/remodelling complexes at specific sites of the genome.
###end p 32
###begin title 33
Conclusion
###end title 33
###begin p 34
###xml 164 173 164 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
Evidence has been accumulating that RNA plays a role in transcriptional control. Both wild type MTGs and leukemia-associated AML1-MTG fusion proteins display novel in vitro RNA-binding properties. These findings lend support to the hypothesis of the involvement of an RNA component in MTG-mediated chromatin regulation.
###end p 34
###begin title 35
Methods
###end title 35
###begin title 36
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In silico </italic>
In silico analyses
###end title 36
###begin p 37
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 457 462 <span type="species:ncbi:10090">mouse</span>
###xml 490 497 <span type="species:ncbi:9031">Chicken</span>
###xml 522 529 <span type="species:ncbi:8355">Xenopus</span>
###xml 571 576 <span type="species:ncbi:9606">human</span>
Prediction of RNA-binding residues in the primary structure of the MTG8b protein (Acc. # NP_783552) was performed by using the both the BindN [39] and the RNABindR [43] software. Prediction of the positively charged, nucleid-acid-binding patches of the MTG8 NHR4 solution structure (PDB ID # 2OD1) was performed by using Patch Finder Plus [41,42]. The SBR region was further analyzed by multiple alignments with both the MTG8 proteins of different species (mouse MTG8, Acc. # NP_001104497; Chicken MTG8, Acc. # NP_990075, Xenopus MTG8, Acc. # NP_001089065) and the other human MTG proteins (MTG16a, Acc. # NP_005178; MTGR1b, Acc # NP_005084). Multiple alignments were obtained by using the DNAman software followed by minor manual adjustments.
###end p 37
###begin title 38
Cell cultures and transfections
###end title 38
###begin p 39
###xml 182 183 176 177 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 93 97 <span type="species:ncbi:9913">calf</span>
COS-7 were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS) and 1% antibiotics (penicillin and streptomycin) at 37degreesC and 5% CO2. Cells were transiently transfected with 1 mug of plasmid DNA and Lipofectamine Plus (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions and harvested after 48 h.
###end p 39
###begin title 40
Constructs
###end title 40
###begin p 41
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FMR1 </italic>
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 299 306 299 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTG16a </italic>
###xml 512 519 512 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTGR1a </italic>
###xml 747 753 747 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTG8b </italic>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 935 941 935 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTG8b </italic>
###xml 1508 1518 1492 1502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AML1-MTG8 </italic>
###xml 1522 1533 1506 1517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AML1-MTG16 </italic>
###xml 167 170 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
The psf2 construct containing FMR1 cDNA was previously described [47]. The cDNAs of wild type MTGs, AML1-MTGs and MTG8 deletion mutants were subcloned by PCR into the CMV-driven mammalian expression vector pcDNA3.1/V5-His TOPO (Invitrogen) leaving or introducing a stop-codon before the V5-His tag. MTG16a cDNA was kindly provided by Drs Kosoda and Ohki (National Cancer Research Institute, Tokyo, Japan) and amplified with primers P44 (5'-ACC ATG CCG GCT TCA AGA CT-3') and P10 (5'-CAG GGG CCA GTG GGG TCA-3'). MTGR1a cDNA was kindly provided by Dr I. Kitabayashi (National Cancer Research Institute, Tokyo, Japan) and amplified with primers P12 (5'-AAC CAT GCC TGG ATC GCC TG-3') and P13 (5'-AGC AGA GTC CGG GGC TCA G-3'). The cDNA of wild type MTG8b was amplified from pCMV-MTG8b [16] with primers P122 (5'-ACC ATG ATA TCT GTC AAA AGA AAC-3') and P7 (5'-TCA CGT CTA GCG AGG GGT TG-3'). The MTG8 deletion mutants were amplified from MTG8b cDNA with the following primers: MTG8Delta1, lacking the region coding for amino acids 449-604, with primers P122 and P123 (5'-CTC CTC AGC TTA CTT CCA GAT C-3'); MTG8Delta2, lacking the region coding for amino acids 1-304, with primers P125 (5'-ACC ATG GCC ATT GCC CAC CAC TAC-3') and P7; MTG8Delta3, lacking the region coding for amino acids 1-329, with primers P157 (5'-GTT ATG GGG TTG CAT GGC ACA CG-3') and P7; MTG8Delta4, lacking the region coding for amino acids 1-329 and 514-604, with primers P157 and P124 (5'-CCA GCA ACT CTA GCT TGA ATC C-3'). The cDNAs of AML1-MTG8 and AML1-MTG16 type1 were kindly provided by Dr I. Kitabayashi and amplified with primers P51 (5'-ACC ATG CGT ATC CCC GTA GAT G-3') and P7, and P51-P10, respectively.
###end p 41
###begin title 42
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
In vitro transcription translation
###end title 42
###begin p 43
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
In vitro transcription/translation was performed with TnT Quick Coupled Transcription/Translation System (Promega, Madison, WI) according to the manufacturer's instructions. 1 mug of plasmid DNA containing a T7 promoter was used in each reaction. The samples were directly used for the RNA-binding assay.
###end p 43
###begin title 44
RNA-binding assay
###end title 44
###begin p 45
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 126 128 126 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 216 217 216 217 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 338 340 337 339 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1334 1336 1314 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1380 1382 1360 1362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1222 1228 <span type="species:ncbi:9986">rabbit</span>
###xml 1264 1270 <span type="species:ncbi:9986">rabbit</span>
###xml 1306 1312 <span type="species:ncbi:9986">rabbit</span>
###xml 1353 1358 <span type="species:ncbi:10090">mouse</span>
###xml 1433 1438 <span type="species:ncbi:10090">mouse</span>
###xml 1475 1480 <span type="species:ncbi:10090">mouse</span>
###xml 1591 1597 <span type="species:ncbi:9986">rabbit</span>
###xml 1607 1612 <span type="species:ncbi:10090">mouse</span>
The RNA-binding assay was based on the affinity for different RNA homopolymers, as previously described [32]. Approximately 106 transfected cells were homogenized in binding buffer (10 mM Tris-HCl pH 7.5, 2.5 mM MgCl2, 0.5% Triton X100) containing NaCl in the indicated concentrations (150 mM when not mentioned otherwise) and 50 muM ZnCl2 when not otherwise indicated. The samples were sonicated 2-3 times for 15 sec. and spun down for 5' at 13000 rpm at 4degreesC. A small part of the homogenate was saved as total sample and the rest was split and used for binding to 60 mul of Sepharose 4B-poly(U), -poly(A) (both from GE Healthcare, Piscataway, NJ), -poly (C) or -poly(G) (both from Sigma) beads previously washed and diluted 1:1 in binding buffer. As a negative control we either used beads treated with 50 U/ml micrococcal nuclease for 1 h 30degreesC or ECH Sepharose 4B (GE Healthcare). After incubation at 4degreesC for 1 h on a rocking platform, the beads were washed 5 times with 1 ml binding buffer and finally eluted with NuPage LDS Sample Buffer (Invitrogen). Samples were analyzed on SDS-PAGE followed by Western blotting. Immunodetection was performed with antibodies that we developed against MTG8 (AB-8, rabbit polyclonal, 1:2000), MTG16 (AB-16, rabbit polyclonal, 1:2000), MTGR1 (AB-R1, rabbit polyclonal, 1:2000) [16], and FMRP (1A, mouse monoclonal, 1:4000) [35]. Commercial antibodies were used for BSA (Sigma, mouse monoclonal, 1:1000) and GFP (Roche, mouse monoclonal, 1:1000). Incubation with the primary antibody was followed by incubation with HRP-conjugated anti-rabbit and anti-mouse secondary antibodies (GE Healthcare, 1:5000) and ECL detection (GE Healthcare).
###end p 45
###begin title 46
Authors' contributions
###end title 46
###begin p 47
###xml 57 67 57 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
SR contributed to conceive the hypothesis, performed the in silico analyses, designed and carried out the experiments, and drafted the manuscript. LV contributed to perform the RNA-binding experiments. NS contributed to conceive the hypothesis, co-ordinated the overall project, and critically revised the manuscript. ATH contributed to conceive the hypothesis, provided experimental advice, and reviewed the manuscript.
###end p 47
###begin title 48
Acknowledgements
###end title 48
###begin p 49
This work was supported through Erasmus MC funds (ATH), an AIRC grant (NS) and, in part, by the NCI Cancer Center Support Grant to Roswell Park Cancer Institute (CA016056). SR was supported by a postdoctoral fellowship from the University of Milan (Italy).
###end p 49
###begin article-title 50
Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt
###end article-title 50
###begin article-title 51
The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript
###end article-title 51
###begin article-title 52
Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8;21) leukemic cells
###end article-title 52
###begin article-title 53
EHT, a new member of the MTG8/ETO gene family, maps on 20q11 region and is deleted in acute myeloid leukemias [letter]
###end article-title 53
###begin article-title 54
###xml 30 35 <span type="species:ncbi:9606">human</span>
CBFA2T1, a gene rearranged in human leukemia, is a member of a multigene family
###end article-title 54
###begin article-title 55
The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1
###end article-title 55
###begin article-title 56
The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family
###end article-title 56
###begin article-title 57
A TAF4-homology domain from the corepressor ETO is a docking platform for positive and negative regulators of transcription
###end article-title 57
###begin article-title 58
Oligomerization of ETO is obligatory for corepressor interaction
###end article-title 58
###begin article-title 59
Multiple regions of eto cooperate in transcriptional repression
###end article-title 59
###begin article-title 60
ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain
###end article-title 60
###begin article-title 61
AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML
###end article-title 61
###begin article-title 62
Significance of MTG8 in leukemogenesis
###end article-title 62
###begin article-title 63
ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors
###end article-title 63
###begin article-title 64
###xml 103 108 <span type="species:ncbi:9606">human</span>
ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex
###end article-title 64
###begin article-title 65
The transcriptional corepressor MTG16a contains a novel nucleolar targeting sequence deranged in t (16; 21)-positive myeloid malignancies
###end article-title 65
###begin article-title 66
Transcriptional repression by leukaemia-associated ETO family members can be independent of oligomerization and coexpressed hSIN3B and N-CoR
###end article-title 66
###begin article-title 67
Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO
###end article-title 67
###begin article-title 68
CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3
###end article-title 68
###begin article-title 69
The MTG proteins: chromatin repression players with a passion for networking
###end article-title 69
###begin article-title 70
Role of co-repressors in transcriptional repression mediated by the t(8;21), t(16;21), t(12;21), and inv(16) fusion proteins
###end article-title 70
###begin article-title 71
###xml 30 35 <span type="species:ncbi:9606">human</span>
Core binding factor genes and human leukemia
###end article-title 71
###begin article-title 72
Transcription factor fusions in acute leukemia: variations on a theme
###end article-title 72
###begin article-title 73
The 8;21 translocation in leukemogenesis
###end article-title 73
###begin article-title 74
Translating the histone code into leukemia
###end article-title 74
###begin article-title 75
A distinct epigenetic signature at targets of a leukemia protein
###end article-title 75
###begin article-title 76
Myeloid maturation block by AML1-MTG16 is associated with Csf1r epigenetic downregulation
###end article-title 76
###begin article-title 77
Non-coding RNA
###end article-title 77
###begin article-title 78
Non-coding RNAs: lost in translation?
###end article-title 78
###begin article-title 79
An expanding universe of noncoding RNAs
###end article-title 79
###begin article-title 80
Having it both ways: transcription factors that bind DNA and RNA
###end article-title 80
###begin article-title 81
Classification and purification of proteins of heterogeneous nuclear ribonucleoprotein particles by RNA-binding specificities
###end article-title 81
###begin article-title 82
The protein product of the fragile x gene, FMR1, has characteristics of an RNA-binding protein
###end article-title 82
###begin article-title 83
###xml 29 52 <span type="species:ncbi:7227">Drosophila melanogaster</span>
Characterization of dFMR1, a Drosophila melanogaster homolog of the fragile x mental retardation protein
###end article-title 83
###begin article-title 84
Characterization of FMR1 proteins isolated from different tissues
###end article-title 84
###begin article-title 85
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
###xml 118 123 <span type="species:ncbi:10090">mouse</span>
Structural properties and RNA-binding activities of two RNA recognition motifs of a mouse neural RNA-binding protein, mouse-Musashi-1
###end article-title 85
###begin article-title 86
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
KIN17 encodes an RNA-binding protein and is expressed during mouse spermatogenesis
###end article-title 86
###begin article-title 87
###xml 57 64 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
RNA chaperone activity and RNA-binding properties of the E. coli protein StpA
###end article-title 87
###begin article-title 88
BindN: a web-based tool for efficient prediction of DNA and RNA binding sites in amino acid sequences
###end article-title 88
###begin article-title 89
Structural basis for recognition of SMRT/N-CoR by the MYND domain and its contribution to AML1/ETO's activity
###end article-title 89
###begin article-title 90
Classifying RNA-binding proteins based on electrostatic properties
###end article-title 90
###begin article-title 91
Patch Finder Plus (PFplus): a web server for extracting and displaying positive electrostatic patches on protein surfaces
###end article-title 91
###begin article-title 92
RNABindR: a server for analyzing and predicting RNA-binding sites in proteins
###end article-title 92
###begin article-title 93
RNA-binding proteins: modular design for efficient function
###end article-title 93
###begin article-title 94
Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein
###end article-title 94
###begin article-title 95
Transcribed short tandem repeats occur in couples with strongly preferred registers
###end article-title 95
###begin article-title 96
Characterization and localization of the FMR-1 gene product associated with fragile x syndrome
###end article-title 96

